The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2024 | Vaccinations and infection prophylaxis in multiple myeloma
Heinz Ludwig, MD, Wilhelminen Cancer Research Institute, Vienna, Austria, emphasizes the critical role of vaccinations in preventing infections in patients with multiple myeloma (MM). He particularly highlights the importance of vaccines for influenza, pneumococcal disease, and COVID-19. This interview took place at The 10th World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Research Funding: Amgen, Takeda, Sanofi
Speaker‘s Bureau, Advisory Boards: Amgen, Takeda, Celgene-BMS, Janssen, Pfizer, Sanofi
